References - iarc

689. Di Domenico A, Stangl F, Bennington J
(1982). Leiomyosarcoma of the broad ligament.
Gynecol Oncol 13: 412-415. 690. Di
Sant'Agnese PA, Knowles DM (1980).
Extracardiac rhabdomyoma: a clinicopathologic
study and review of the literature.
Cancer 46: 780-789.
691. Diab SG, Clark GM, Osborne CK, Libby
A, Allred DC, Elledge RM (1999). Tumor
characteristics and clinical outcome of
tubular and mucinous breast carcinomas.
J Clin Oncol 17: 1442-1448.
692. Diaz NM, McDivitt RW, Wick MR
(1991). Microglandular adenosis of the
breast. An immunohistochemical comparison
with tubular carcinoma. Arch Pathol
Lab Med 115: 578-582.
693. Diaz NM, Palmer JO, McDivitt RW
(1991). Carcinoma arising within fibroadenomas
of the breast. A clinicopathologic
study of 105 patients. Am J Clin Pathol 95:
614-622.
694. Dickersin GR, Maluf HM, Koerner FC
(1997). Solid papillary carcinoma of breast:
an ultrastructural study. Ultrastruct Pathol
21: 153-161.
695. Dickersin GR, Scully RE (1993). An
update on the electron microscopy of
small cell carcinoma of the ovary with
hypercalcemia. Ultrastruct Pathol 17: 411-
422.
696. Dickersin GR, Scully RE (1998). Ovarian
small cell tumors: an electron microscopic
review. Ultrastruct Pathol 22: 199-226.
697. Dickersin GR, Young RH, Scully RE
(1995). Signet-ring stromal and related
tumors of the ovary. Ultrastruct Pathol 19:
401-419.
698. Dickson JM, Mansel RE (2000). ABC of
Breast Diseases. Symptoms, Assessment
and Guidelines for Referral. 2nd ed. BMJ
Books: London, pp. 1-5.
699. DiCostanzo D, Rosen PP, Gareen I,
Franklin S, Lesser M (1990). Prognosis in
infiltrating lobular carcinoma. An analysis
of "classical" and variant tumors. Am J
Surg Pathol 14: 12-23.
700. Dietl J, Horny HP, Ruck P, Kaiserling E
(1993). Dysgerminoma of the ovary. An
immunohistochemical study of tumor-infiltrating
lymphoreticular cells and tumor
cells. Cancer 71: 2562-2568.
701. Dietrich CU, Pandis N, Teixeira MR,
Bardi G, Gerdes AM, Andersen JA, Heim S
(1995). Chromosome abnormalities in
benign hyperproliferative disorders of
epithelial and stromal breast tissue. Int J
Cancer 60: 49-53.
702. Dina R, Eusebi V (1997). Clear cell
tumors of the breast. Semin Diagn Pathol
14: 175-182.
703. Dinh TV, Slavin RE, Bhagavan BS,
Hannigan EV, Tiamson EM, Yandell RB
(1989). Mixed mullerian tumors of the
uterus: a clinicopathologic study. Obstet
Gynecol 74: 388-392.
704. Dixon AR, Ellis IO, Elston CW, Blamey
RW (1991). A comparison of the clinical
metastatic patterns of invasive lobular and
ductal carcinomas of the breast. Br J
Cancer 63: 634-635.
705. Dixon JM, Anderson TJ, Page DL, Lee
D, Duffy SW (1982). Infiltrating lobular carcinoma
of the breast. Histopathology 6:
149-161.
706. Dixon JM, Lumsden AB, Krajewski A,
Elton RA, Anderson TJ (1987). Primary lymphoma
of the breast. Br J Surg 74: 214-216.
707. Dixon JM, Sainsbury JRC (1998).
Handbook of Diseases of the Breast. 2nd
ed. Churchill Livingstone: Edinburgh.
708. Dobbs SP, Shaw PA, Brown LJ,
Ireland D (1998). Borderline malignant
change in recurrent mullerian papilloma of
the vagina. J Clin Pathol 51: 875-877.
709. Dockerty MB, Masson JC (1944).
Ovarian fibromas: a clinical and pathologi -
cal study of two hundred-and eighty-three
cases. Am J Obstet Gynecol 47: 741-752.
710. Dodge JA, Eltabbakh GH, Mount SL,
Walker RP, Morgan A (2001). Clinical features
and risk of recurrence among
patients with vaginal intraepithelial neoplasia.
Gynecol Oncol 83: 363-369.
711. Domagala W, Harezga B, Szadowska
A, Markiewski M, Weber K, Osborn M
(1993). Nuclear p53 protein accumulates
preferentially in medullary and high-grade
ductal but rarely in lobular breast carcino -
mas. Am J Pathol 142: 669-674.
712. Done SJ, Eskandarian S, Bull S,
Redston M, Andrulis IL (2001). p53 missense
mutations in microdissected highgrade
ductal carcinoma in situ of the
breast. J Natl Cancer Inst 93: 700-704.
713. Donegan WL, Redlich PN, Lang PJ,
Gall MT (1998). Carcinoma of the breast in
males: a multiinstitutional survey. Cancer
83: 498-509.
714. Donehower LA, Harvey M, Slagle BL,
McArthur MJ, Montgomery CA Jr., Butel
JS, Bradley A (1992). Mice deficient for p53
are developmentally normal but susceptible
to spontaneous tumours. Nature 356:
215-221.
715. Dong C, Hemminki K (2001).
Modification of cancer risks in offspring by
sibling and parental cancers from
2,112,616 nuclear families. Int J Cancer 92:
144-150.
715 a. Dong HJ, Li JG, Zeng JH, Huang SZ
(1986). Papillary adenocarcinoma of the
broad ligament. Report of a case and
review of literature. Chin Med J (Engl) 99:
431-432.
716. Donkers B, Kazzaz BA, Meijering JH
(1972). Rhabdomyosarcoma of the corpus
uteri. Report of two cases with review of
the literature. Am J Obstet Gynecol 114:
1025-1030.
717. Donnell RM, Rosen PP, Lieberman PH,
Kaufman RJ, Kay S, Braun DW Jr., Kinne
DW (1981). Angiosarcoma and other vascular
tumors of the breast. Am J Surg
Pathol 5: 629-642.
718. Dougherty CM, Cunningham C, Mickal
A (1978). Choriocarcinoma with metastasis
in a postmenopausal woman. Am J Obstet
Gynecol 132: 700-701.
719. Douglas-Jones AG, Pace DP (1997).
Pathology of R4 spiculated lesions in the
breast screening programme.
Histopathology 30: 214-220.
720. Downey GO, Okagaki T, Ostrow RS,
Clark BA, Twiggs LB, Faras AJ (1988).
Condylomatous carcinoma of the vulva
with special reference to human papillomavirus
DNA. Obstet Gynecol 72: 68-73.
721. Drew PA, al Abbadi MA, Orlando CA,
Hendricks JB, Kubilis PS, Wilkinson EJ
(1996). Prognostic factors in carcinoma of
the vulva: a clinicopathologic and DNA
flow cytometric study. Int J Gynecol
Pathol 15: 235-241.
722. Driscoll SG (1963). Choriocarcinoma.
An "incidental finding" within a term placenta.
Obstet Gynecol 21: 96-101.
723. Droufakou S, Deshmane V, Roylance
R, Hanby A, Tomlinson I, Hart IR (2001).
Multiple ways of silencing E-cadherin
gene expression in lobular carcinoma of
the breast. Int J Cancer 92: 404-408.
724. Droulias CA, Sewell CW, McSweeney
MB, Powell RW (1976). Inflammatory carcinoma
of the breast: A correlation of clinical,
radiologic and pathogic findings. Ann
Surg 184: 217-222.
725. du Toit RS, Locker AP, Ellis IO, Elston
CW, Nicholson RI, Blamey RW (1989).
Invasive lobular carcinomas of the breast-
-the prognosis of histopathological subtypes.
Br J Cancer 60: 605-609.
726. Dubeau L (1999). The cell of origin of
ovarian epithelial tumors and the ovarian
surface epithelium dogma: does the
emperor have no clothes? Gynecol Oncol
72: 437-442.
727. Duggan MA, Hugh J, Nation JG,
Robertson DI, Stuart GC (1989).
Ependymoma of the uterosacral ligament.
Cancer 64: 2565-2571.
728. Dumont-Herskowitz RA, Safaii HS,
Senior B (1978). Ovarian fibromata in four
successive generations. J Pediatr 93: 621-
624.
729. Dunaif A, Hoffman AR, Scully RE, Flier
JS, Longcope C, Levy LJ, Crowley WF Jr.
(1985). Clinical, biochemical, and ovarian
morphologic features in women with acanthosis
nigricans and masculinization.
Obstet Gynecol 66: 545-552.
7 3 0 . Dungar CF, Wilkinson EJ (1995).
Vaginal columnar cell metaplasia. An
acquired adenosis associated with topical
5-fluorouracil therapy. J Reprod Med 40:
361-366.
731. Dunlop MG, Farrington SM, Carothers
AD, Wyllie AH, Sharp L, Burn J, Liu B,
Kinzler KW, Vogelstein B (1997). Cancer
risk associated with germline DNA mismatch
repair gene mutations. Hum Mol
Genet 6: 105-110.
732. Dupont WD, Page DL (1985). Risk factors
for breast cancer in women with proliferative
breast disease. N Engl J Med 312:
146-151.
733. Dupont WD, Page DL (1987). Breast
cancer risk associated with proliferative
disease, age at first birth, and a family his -
tory of breast cancer. Am J Epidemiol 125:
769-779.
734. Dupont WD, Page DL, Parl FF,
Vnencak-Jones CL, Plummer WD Jr.,
Rados MS, Schuyler PA (1994). Long-term
risk of breast cancer in women with
fibroadenoma. N Engl J Med 331: 10-15.
735. Dupont WD, Parl FF, Hartmann WH,
Brinton LA, Winfield AC, Worrell JA,
Schuyler PA, Plummer WD (1993). Breast
cancer risk associated with proliferative
breast disease and atypical hyperplasia.
Cancer 71: 1258-1265.
7 3 6 . Durkop H, Foss HD, Eitelbach F,
Anagnostopoulos I, Latza U, Pileri S, Stein
H (2000). Expression of the CD30 antigen in
non-lymphoid tissues and cells. J Pathol
190: 613-618.
737. Durst M, Gissmann L, Ikenberg H, zur
Hausen H (1983). A papillomavirus DNA
from a cervical carcinoma and its prevalence
in cancer biopsy samples from different
geographic regions. Proc Natl Acad
Sci USA 80: 3812-3815.
738. Duska LR, Flynn C, Goodman A (1998).
Masculinizing sclerosing stromal cell
tumor in pregnancy: report of a case and
review of the literature. Eur J Gynaecol
Oncol 19: 441-443.
739. Duun S (1994). Bilateral virilizing hilus
(Leydig) cell tumors of the ovary. Acta
Obstet Gynecol Scand 73: 76-77.
740. Duvall E, Survis JA (1983). Borderline
tumour of the broad ligament. Case report.
Br J Obstet Gynaecol 90: 372-375.
741. Easton DF (1994). Cancer risks in A-T
heterozygotes. Int J Radiat Biol 66: S177-
S182.
742. Easton DF, Ford D, Bishop DT (1995).
Breast and ovarian cancer incidence in
BRCA1-mutation carriers. Breast Cancer
Linkage Consortium. Am J Hum Genet 56:
265-271.
743. Easton DF, Matthews FE, Ford D,
Swerdlow AJ, Peto J (1996). Cancer mortality
in relatives of women with ovarian
cancer: the OPCS Study. Office of
Population Censuses and Surveys. Int J
Cancer 65: 284-294.
744. Easton DF, Steele L, Fields P, Ormiston
W, Averill D, Daly PA, McManus R,
Neuhausen SL, Ford D, Wooster R,
Cannon-Albright LA, Stratton MR, Goldgar
DE (1997). Cancer risks in two large breast
cancer families linked to BRCA2 on chromosome
13q12-13. Am J Hum Genet 61:
120-128.
745. Ebrahim S, Daponte A, Smith TH,
Tiltman A, Guidozzi F (2001). Primary mucinous
adenocarcinoma of the vagina.
Gynecol Oncol 80: 89-92.
746. Eckstein RP, Paradinas FJ, Bagshawe
KD (1982). Placental site trophoblastic
tumour (trophoblastic pseudotumour): a
study of four cases requiring hysterectomy
including one fatal case. Histopathology 6:
211-226. 747. Eckstein RP, Russell P,
Friedlander ML, Tattersall MH, Bradfield A
(1985). Metastasizing placental site trophoblastic
tumor: a case study. H u m
Pathol 16: 632-636.
748. Eddy GL, Marks RD Jr., Miller MC III,
Underwood PB Jr. (1991). Primary invasive
vaginal carcinoma. Am J Obstet Gynecol
165: 292-296.
749. Eeles RA (1999). Screening for heredi -
tary cancer and genetic testing, epitomized
by breast cancer. Eur J Cancer 35:
1954-1962.
7 5 0 . Egan AJ, Russell P (1996). Transitional
(urothelial) cell metaplasia of the fallopian
tube mucosa: morphological assessment of
three cases. Int J Gynecol Pathol 15: 72-76.
751. Egan RL (1976). Bilateral breast carcinomas:
Role of mammography. Cancer 38:
931-938.
752. Eggers JW, Chesney TM (1984).
Squamous cell carcinoma of the breast: a
clinicopathologic analysis of eight cases
and review of the literature.Hum Pathol 15:
526-531.
753. Ehrlich CE, Roth LM (1971). The
Brenner tumor. A clinicopathologic study
of 57 cases. Cancer 27: 332-342.
754. Eichhorn JH, Bell DA, Young RH,
Scully RE (1999). Ovarian serous borderline
tumors with micropapillary and cribriform
patterns: a study of 40 cases and comparison
with 44 cases without these patterns.
Am J Surg Pathol 23: 397-409.
755. Eichhorn JH, Bell DA, Young RH,
Swymer CM, Flotte TJ, Preffer RI, Scully RE
(1992). DNA content and proliferative
activity in ovarian small cell carcinomas of
the hypercalcemic type. Implications for
diagnosis, prognosis, and histogenesis.
Am J Clin Pathol 98: 579-586.
756. Eichhorn JH, Lawrence WD, Young
RH, Scully RE (1996). Ovarian neuroendocrine
carcinomas of non-small-cell type
associated with surface epithelial adenocarcinomas.
A study of five cases and
review of the literature. Int J Gynecol
Pathol 15: 303-314.
References 383